Loading Results

Clinical trials

Showing   of 23 results

Amrou Sarraj, MD

University Hospitals Awarded $7 Million by PCORI to Study Endovascular Thrombectomy in Patients Presenting Beyond 24 Hours

Dr. Amrou Sarraj will lead the study, which aims to provide deterministic evidence of clinical benefit due to addition of endovascular thrombectomy to standard medical care in this population.

BAFF CAR T

Phase 1 BAFF CAR T Clinical Trial for Patients with Relapsed and Refractory Multiple Myeloma Underway at UH Seidman Cancer Center

Study is being done through an agreement between UH and Luminary Therapeutics.

University Hospitals Rainbow Babies & Children’s Sickle Cell Disease Patient to Represent the Hospital in Washington, DC

During the 2024 Children’s Hospital Association Family Advocacy Day Canaan Evans and his mom, Arenda will discuss their experience of participating in a clinical trial and undergoing an investigational treatment he says changed his life.

CID group logos

Cleveland Innovation District Partners Exceeding Many Targets Set by State and JobsOhio

25 examples of progress showcase the impact of successful collaboration.

Amrou Sarraj, MD

International Study Finds Thrombectomy Highly Effective Long-Term Treatment for Large Strokes

Led by University Hospitals stroke director Amrou Sarraj, MD, SELECT2 study results in The Lancet presented at International Stroke Conference.

UH and Oxford Therapeutics launch event October 2023

The Oxford-Harrington Rare Disease Centre Launches Pioneering Therapeutics Accelerator to Advance Innovative Treatments for Rare Diseases

The Therapeutics Accelerator (the ‘Accelerator’) will identify, fund and advance innovative projects from academic partners in the U.K. and U.S. with the goal to deliver 40 new potentially life-changing therapies for rare diseases into clinical...

Harrington Discovery Institute

Harrington Discovery Institute Scholar Successfully Moves New Drug for Rare, Genetic Eye Disease into Clinical Trial

Richard Kramer, PhD, hopes to help patients with retinitis pigmentosa.

New Alzheimer's Disease Study Seeks Northeast Ohio Volunteers with Down Syndrome

As many as eight in 10 people with Down syndrome develop Alzheimer’s disease; new study needs volunteers to help identify causes and treatments

Results are loading...